Index of reports
> Cases with Conjunctivitis Bacterial (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Fluorescite (Fluorescein Ophthalmic) where reactions include conjunctivitis bacterial. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Fluorescite side effects in 67 year old male
Reported by a physician from Japan on 2012-02-16
Patient: 67 year old male, weighing 67.0 kg (147.4 pounds)
Reactions: Haemophilus Infection, Pyrexia, Angioplasty, Conjunctivitis Bacterial, Renal Impairment, Decreased Appetite, Cough, Inflammation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pletal
Dosage: 100 mg milligram(s), bid, oral
Administration route: Oral
Indication: Peripheral Arterial Occlusive Disease
Start date: 2011-09-17
End date: 2011-09-21
Pletal
Dosage: 100 mg milligram(s), bid, oral
Administration route: Oral
Indication: Renal Impairment
Start date: 2011-09-17
End date: 2011-09-21
Fluorescite
Dosage: 250 mg milligram(s), qd, intravenous
Indication: Diagnostic Procedure
Start date: 2011-09-15
End date: 2011-09-15
Other drugs received by patient: Newtolide (Hydrochlorothiazide) Tablet; Mucodyne (Carbocisteine); Diovan; Fluvastatin; Atelec (Cilnidipine) Tablet; Cellcept; Neoral; Basen (Voglibose) Orodispersible Tablet
Possible Fluorescite side effects in 67 year old male
Reported by a physician from Japan on 2011-11-02
Patient: 67 year old male, weighing 67.0 kg (147.4 pounds)
Reactions: Haemophilus Infection, Pyrexia, Haemodialysis, Conjunctivitis Bacterial, Renal Impairment, Dehydration, Decreased Appetite, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fluorescite
Dosage: 250 mg milligram(s), qd, intravenous
Indication: Diagnostic Procedure
Start date: 2011-09-15
End date: 2011-09-15
Pletal
Dosage: 100 mg milligram(s), bid, oral
Administration route: Oral
Indication: Renal Impairment
Start date: 2011-09-17
End date: 2011-09-21
Pletal
Dosage: 100 mg milligram(s), bid, oral
Administration route: Oral
Indication: Arteriosclerosis Obliterans
Start date: 2011-09-17
End date: 2011-09-21
Other drugs received by patient: Diovan; Neoral; Atelec (Clinidipine); Mucodyne (Carbocisteine); Fluvastatin; Basen (Voglibose); Newtolide (Hydrochlorothiazide); Cellcept
Possible Fluorescite side effects in 67 year old male
Reported by a physician from Japan on 2011-10-25
Patient: 67 year old male, weighing 67.0 kg (147.4 pounds)
Reactions: Transplant Rejection, Upper Respiratory Tract Inflammation, Conjunctivitis Bacterial, Renal Impairment, Dehydration, Decreased Appetite, Cough, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pletal
Dosage: 100 mg milligram(s), bid, oral
Administration route: Oral
Indication: Arteriosclerosis Obliterans
Start date: 2011-09-17
End date: 2011-09-21
Pletal
Dosage: 100 mg milligram(s), bid, oral
Administration route: Oral
Indication: Renal Impairment
Start date: 2011-09-17
End date: 2011-09-21
Fluorescite
Dosage: intravenous
Start date: 2011-09-15
End date: 2011-09-15
Other drugs received by patient: Fluvastatin; Diovan; Cellcept; Newtolide (Hydrochlorothiazide); Basen (Voglibose); Mucodyne (Carbocisteine); Atelec (Clinidipine); Neoral
|